The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting
Christopher D. Pilcher,Clarissa Ospina-Norvell,Aditi Dasgupta,Diane Jones,Wendy Hartogensis,Sandra Torres,Fabiola Calderon,Erin DeMicco,Elvin Geng,Monica Gandhi,Diane V. Havlir,Hiroyu Hatano +11 more
Reads0
Chats0
TLDR
Treatment for HIV infection can be started on the day of diagnosis without impacting the safety or acceptability of ART, and same-day ART may shorten the time to virologic suppression.Abstract:
Background Antiretroviral therapy (ART) is typically begun weeks after HIV diagnosis. We assessed the acceptability, feasibility, safety, and efficacy of initiating ART on the same day as diagnosis. Methods We studied a clinic-based cohort consisting of consecutive patients who were referred with new HIV diagnosis between June 2013 and December 2014. A subset of patients with acute or recent infection ( Results Among 86 patients, 39 were eligible and managed on the RAPID protocol. Thirty-seven (94.9%) of 39 in RAPID began ART within 24 hours. Minor toxicity with the initial regimen occurred in 2 (5.1%) of intervention patients versus none in the nonintervention group. Loss to follow-up was similar in intervention (10.3%) and nonintervention patients (14.9%) during the study. Time to virologic suppression ( Conclusions Treatment for HIV infection can be started on the day of diagnosis without impacting the safety or acceptability of ART. Same-day ART may shorten the time to virologic suppression.read more
Citations
More filters
Journal ArticleDOI
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel
Michael S. Saag,Constance A. Benson,Rajesh T. Gandhi,Jennifer F Hoy,Raphael J. Landovitz,Michael J. Mugavero,Paul E. Sax,Davey M. Smith,Melanie A. Thompson,Susan Buchbinder,Carlos del Rio,Joseph J. Eron,Gerd Fätkenheuer,Huldrych F. Günthard,Jean-Michel Molina,Donna M. Jacobsen,Paul A. Volberding +16 more
TL;DR: Advances in HIV prevention and treatment with antiretroviral drugs continue to improve clinical management and outcomes for individuals at risk for and living with HIV.
Journal ArticleDOI
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Paul E. Sax,Anton Pozniak,M. Luisa Montes,Ellen Koenig,Edwin DeJesus,Hans Jürgen Stellbrink,Andrea Antinori,Kimberly A. Workowski,Jihad Slim,Jacques Reynes,Will Garner,Joseph M. Custodio,Kirsten L. White,Devi SenGupta,Andrew T. A. Cheng,Erin Quirk +15 more
TL;DR: Results are reported from a study comparing initial HIV-1 treatment with bictegravir with a novel INSTI with a high in-vitro barrier to resistance and low potential as a perpetrator or victim of clinically relevant drug interactions, showing non-inferiority of the bictricitabine regimen to the dolutegravIR regimen.
Journal ArticleDOI
Benefits and risks of rapid initiation of antiretroviral therapy.
Nathan Ford,Chantal Migone,Alexandra Calmy,Bernhard Kerschberger,Steve Kanters,Sabin Nsanzimana,Edward J Mills,Graeme Meintjes,Marco Vitoria,Meg Doherty,Zara Shubber +10 more
TL;DR: Findings informed a WHO recommendation supporting accelerated ART initiation, including same day ART start, and are likely to be of particular benefit in those settings where extensive patient preparation prior to starting ART results in long delays.
Journal ArticleDOI
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
Timothy J. Henrich,Hiroyu Hatano,Oliver Bacon,Louise E. Hogan,Rachel L. Rutishauser,Alison L. Hill,Mary F. Kearney,Elizabeth M. Anderson,Susan Buchbinder,Stephanie E. Cohen,Mohamed Abdel-Mohsen,Mohamed Abdel-Mohsen,Christopher W. Pohlmeyer,Rémi Fromentin,Rebecca Hoh,Albert Y. Liu,Joseph M. McCune,Jonathan Spindler,Kelly A. Metcalf-Pate,Kristen S. Hobbs,Cassandra Thanh,Erica A. Gibson,Daniel R. Kuritzkes,Daniel R. Kuritzkes,Robert F. Siliciano,Robert F. Siliciano,Richard W. Price,Douglas D. Richman,Douglas D. Richman,Nicolas Chomont,Janet D. Siliciano,John W. Mellors,Steven A. Yukl,Steven A. Yukl,Joel N. Blankson,Teri Liegler,Steven G. Deeks +36 more
TL;DR: HIV relapse is reported despite initiation of ART at one of the earliest stages of acute HIV infection possible, and the small numbers of latently infected cells in individuals treated during hyperacute infection may be associated with prolonged ART-free remission.
Journal ArticleDOI
Adult antiretroviral therapy guidelines 2017
Graeme Meintjes,Michelle Moorhouse,Sergio Carmona,Natasha Davies,Sipho Dlamini,Cloete van Vuuren,Thandekile C. Manzini,Moeketsi Mathe,Yunus Moosa,Jennifer Nash,Jeremy Nel,Yoliswa Pakade,Joana Woods,Gert U. van Zyl,Francesca Conradie,Francois Venter +15 more
TL;DR: These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015.
References
More filters
Journal ArticleDOI
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Jason P. Fine,Robert Gray +1 more
TL;DR: This article proposes methods for combining estimates of the cause-specific hazard functions under the proportional hazards formulation, but these methods do not allow the analyst to directly assess the effect of a covariate on the marginal probability function.
Journal ArticleDOI
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen,Ying Q. Chen,Marybeth McCauley,Theresa Gamble,Mina C. Hosseinipour,Nagalingeswaran Kumarasamy,James Hakim,Johnstone Kumwenda,Beatriz Grinsztejn,José Henrique Pilotto,Sheela Godbole,Sanjay Mehendale,Suwat Chariyalertsak,Breno Santos,Kenneth H. Mayer,Irving F. Hoffman,Susan H. Eshleman,Estelle Piwowar-Manning,Lei Wang,Joseph Makhema,Lisa A. Mills,Guy de Bruyn,Ian Sanne,Joseph J. Eron,Joel E. Gallant,Diane V. Havlir,Susan Swindells,Heather J. Ribaudo,Vanessa Elharrar,David N. Burns,Taha E. Taha,Karin Nielsen-Saines,David D. Celentano,Myron Essex,Thomas R. Fleming +34 more
TL;DR: In this article, Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples.
Journal ArticleDOI
Prevention of HIV-1 infection with early antiretroviral therapy
TL;DR: The exciting evidence generated by this paper – that antiretroviral treatment of HIV-1 infection definitively reduces the risk of onward transmission of the virus by 96% – was rightly dubbed Science magazine's ‘Breakthrough of the Year’ in 2011.
Journal ArticleDOI
Initiation of antiretroviral therapy in early asymptomatic HIV infection
Sean Emery,Shweta Sharma,Gerd Fätkenheuer,Josep M. Llibre,Jean-Michel Moli,Paula Munderi,Robin Wood,Karin L. Klingman,Simon Collins,H. Clifford Lane,Andrew N. Phil,James D. Neaton +11 more
TL;DR: The initiation of antiretroviral therapy in HIV-positive adults with a CD4+ count of more than 500 cells per cubic millimeter provided net benefits over starting such therapy in patients after the CD4+, but the risks of unscheduled hospital admissions were similar in the two groups.
Journal ArticleDOI
Rates of HIV-1 Transmission per Coital Act, by Stage of HIV-1 Infection, in Rakai, Uganda
Maria J. Wawer,Ronald H. Gray,Nelson K. Sewankambo,David Serwadda,Xianbin Li,Oliver Laeyendecker,Noah Kiwanuka,Godfrey Kigozi,Mohammed Kiddugavu,Tom Lutalo,Fred Nalugoda,Fred Wabwire-Mangen,Mary P. Meehan,Thomas C. Quinn,Thomas C. Quinn +14 more
TL;DR: The rate of HIV transmission per coital act was highest during early-stage infection, which has implications for HIV prevention and for projecting the effects of antiretroviral treatment on HIV transmission.
Related Papers (5)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen,Ying Q. Chen,Marybeth McCauley,Theresa Gamble,Mina C. Hosseinipour,Nagalingeswaran Kumarasamy,James Hakim,Johnstone Kumwenda,Beatriz Grinsztejn,José Henrique Pilotto,Sheela Godbole,Sanjay Mehendale,Suwat Chariyalertsak,Breno Santos,Kenneth H. Mayer,Irving F. Hoffman,Susan H. Eshleman,Estelle Piwowar-Manning,Lei Wang,Joseph Makhema,Lisa A. Mills,Guy de Bruyn,Ian Sanne,Joseph J. Eron,Joel E. Gallant,Diane V. Havlir,Susan Swindells,Heather J. Ribaudo,Vanessa Elharrar,David N. Burns,Taha E. Taha,Karin Nielsen-Saines,David D. Celentano,Myron Essex,Thomas R. Fleming +34 more
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
Christine Danel,Raoul Moh,Delphine Gabillard,Anani Badje,Le Carrou J,Ouassa T,Eric Ouattara,Anzian A,Jean-Baptiste Ntakpe,Albert Minga,Gérard-Menan Kouamé,Bouhoussou F,Emieme A,Abo Kouame,Inwoley A,Toni Td,Ahiboh H,Kabran M,Rabe C,Sidibé B,Nzunetu G,Konan R,Gnokoro J,Gouesse P,Messou E,Dohoun L,Kamagate S,Yao A,Amon S,Kouame Ab,Koua A,Kouamé E,Ndri Y,Ba-Gomis O,Daligou M,Ackoundzé S,Hawerlander D,Ani A,Dembélé F,Koné F,Guéhi C,Kanga C,Koule S,Séri J,Oyebi M,Mbakop N,Makaila O,Babatunde C,Babatounde N,Bleoué G,Tchoutedjem M,Kouadio Ac,Sena G,Yededji Sy,Assi R,Bakayoko A,Mahassadi A,Attia A,Oussou A,Mobio M,Bamba D,Koman M,Horo A,Nina Deschamps,Chenal H,Sassan-Morokro M,Konate S,Aka K,Aoussi E,Journot,Nchot C,Sophie Karcher,Chaix Ml,Christine Rouzioux,Sow Ps,Perronne C,Girard Pm,Menan H,Bissagnene E,Kadio A,Ettiegne-Traore,Moh-Semdé C,Massumbuko Jm,Chêne G,Dosso M,Domoua Sk,N'Dri-Yoman T,Roger Salamon,Serge-Paul Eholié,Xavier Anglaret +89 more
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Myron S. Cohen,Ying Q. Chen,Marybeth McCauley,Theresa Gamble,Mina C. Hosseinipour,Nagalingeswaran Kumarasamy,James Hakim,Johnstone Kumwenda,Beatriz Grinsztejn,José Henrique Pilotto,Sheela Godbole,Suwat Chariyalertsak,Breno Santos,Kenneth H. Mayer,Irving F. Hoffman,Susan H. Eshleman,Estelle Piwowar-Manning,Leslie Cottle,Xinyi C. Zhang,Joseph Makhema,Lisa A. Mills,Ravindre Panchia,Sharlaa Faesen,Joseph J. Eron,Joel E. Gallant,Diane V. Havlir,Susan Swindells,Vanessa Elharrar,David N. Burns,Taha E. Taha,Karin Nielsen-Saines,David D. Celentano,Max Essex,Sarah E. Hudelson,Andrew D. Redd,Thomas R. Fleming +35 more
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel
Michael S. Saag,Constance A. Benson,Rajesh T. Gandhi,Jennifer F Hoy,Raphael J. Landovitz,Michael J. Mugavero,Paul E. Sax,Davey M. Smith,Melanie A. Thompson,Susan Buchbinder,Carlos del Rio,Joseph J. Eron,Gerd Fätkenheuer,Huldrych F. Günthard,Jean-Michel Molina,Donna M. Jacobsen,Paul A. Volberding +16 more